Search results
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 3 hours agoShares of the struggling vaccine developer Novavax (NASDAQ: NVAX) bounded 98.7% higher on Friday,...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 19 hours agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
CNBC· 18 hours agoA vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. ...
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
BenefitsPRO· 21 hours agoNovavax will receive $500 million in upfront payments as well as a further $700 million if all...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 4 days agoA health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 1 day ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
Shah Capital urges Novavax shareholders to vote against three directors
Reuters via AOL· 1 week ago(Reuters) -Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
Novavax's Q1 Results Are Overshadowed by Its Sanofi Partnership | The Motley Fool
The Motley Fool· 20 hours agoNovavax (NVAX 47.63%) released its first-quarter earnings report on May 10, and the vaccine-focused biotechnology company's numbers reflected notable progress ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 16 hours agoNovavax to Participate in BofA Securities 2024 Health Care Conference PR Newswire GAITHERSBURG, Md., May 13, 2024 GAITHERSBURG, Md., May 13, 2024 /PRNewswire/ -- ...
Novavax Shares Pop Another 50% Following Sanofi Deal
Market Watch· 18 hours agoShares of Novavax continued their ascent on Monday, adding to gains from last week after the company announced a licensing deal with Sanofi. Novavax said ...